Literature DB >> 17976652

Histopathology of central nervous system lesions in Behçet's disease.

Shunsei Hirohata1.   

Abstract

Central nervous system (CNS) involvement in Behçet's disease, usually called neuro-Behçet's syndrome (NB), is one of the most serious complications of the disease. In the present study, we carried out immunohistological examination of biopsied or autopsied brain tissues from 3 patients with different types of NB, acute NB, chronic progressive NB, and NB in a long-term remission. Histopathology of mass lesion in acute NB revealed infiltration of mononuclear cells around small vessels, consisting of CD45RO+ T lymphocytes and CD68+ monocytes with few CD20+ B lymphocytes. Of interest, TUNNEL staining disclosed that most neurons were undergoing apoptosis in the inflammatory lesion. In chronic progressive NB, similar histopathological changes were noted in pons, cerebellum, medulla, internal capsule, and midbrain, although the degree of mononuclear cell infiltration was modest. There were also scattered foci of neurons undergoing apoptosis with formation of a few binucleated neurons. The most prominent feature of NB in a long-term remission was atrophy of basal pons with formation of cystic or moth-eaten lesions, consisting of isomorphic gliosis with viable neurons. There were still scattered foci of perivascular cuffing of T lymphocytes and monocytes. These results emphasize the common features throughout the courses of NB, perivascular cuffing of T lymphocytes and monocytes, irrespective of the clinical phenotypes. More importantly, it is suggested that soluble factors produced by infiltrating cells, including IL-6, might play a role in the induction of apoptosis of neurons in NB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976652     DOI: 10.1016/j.jns.2007.09.041

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  29 in total

1.  Evaluation of parenchymal neuro-behçet disease by using susceptibility-weighted imaging.

Authors:  S Albayram; S Saip; Z I Hasiloglu; M Teke; E Ceyhan; M Tutuncu; H Selcuk; A Kina; A Siva
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

Review 2.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

3.  [Neurological manifestations of vasculitis and primary central nervous system vasculitis].

Authors:  T Magnus; A Melms; I Kötter; J U Holle
Journal:  Z Rheumatol       Date:  2012-09       Impact factor: 1.372

Review 4.  Neurological complications of Behçet's syndrome.

Authors:  Desmond Kidd
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

5.  Mass-like lesions as a rare form of neuro-Behçet's disease: A case report and review of the literature.

Authors:  Nazife Şule Yasar Bilge; Suzan Şaylısoy; Timuçin Kaşifoglu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2014-03-01

Review 6.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 7.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

8.  Transient involvement of the cerebral cortex in a flare of Behçet's syndrome.

Authors:  Walter Conca; Soliman A Kamel; Dominic Venne; Peter Corr
Journal:  Rheumatol Int       Date:  2010-01-07       Impact factor: 2.631

Review 9.  Differential diagnosis and management of Behçet syndrome.

Authors:  Nicola L Ambrose; Dorian O Haskard
Journal:  Nat Rev Rheumatol       Date:  2012-09-25       Impact factor: 20.543

Review 10.  Neurological complications of Behçet's syndrome.

Authors:  D P Kidd
Journal:  J Neurol       Date:  2017-03-10       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.